Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma
Clinical trial NCT00969917 · WITHDRAWN
Trial details
- NCT number
- NCT00969917
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.